FDCC
TMO icon

Foster Dykema Cabot & Co’s Thermo Fisher Scientific TMO Stock Holding History

Foster Dykema Cabot & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$21.6M Sell
42,640
-18
-0% -$9.59K 2.61% 10
2023
Q2 		$22.3M Buy
42,658
+255
+0.6% +$138K 2.62% 11
2023
Q1 		$24.4M Buy
42,403
+1,030
+2% +$581K 3.14% 6
2022
Q4 		$22.8M Sell
41,373
-926
-2% -$491K 3.19% 4
2022
Q3 		$21.5M Buy
42,299
+86
+0.2% +$48.1K 2.69% 5
2022
Q2 		$22.9M Sell
42,213
-168
-0.4% -$92.5K 2.83% 5
2022
Q1 		$25M Buy
42,381
+131
+0.3% +$75.3K 3.02% 9
2021
Q4 		$28.2M Buy
42,250
+1,104
+3% +$689K 3.18% 5
2021
Q3 		$23.5M Sell
41,146
-326
-0.8% -$179K 2.93% 5
2021
Q2 		$20.9M Buy
41,472
+545
+1% +$257K 2.61% 9
2021
Q1 		$18.7M Buy
40,927
+587
+1% +$280K 2.52% 9
2020
Q4 		$18.8M Sell
40,340
-4,234
-9% -$1.99M 2.64% 8
2020
Q3 		$19.7M Buy
44,574
+303
+0.7% +$125K 3.23% 8
2020
Q2 		$16M Sell
44,271
-190
-0.4% -$63.7K 2.9% 8
2020
Q1 		$12.6M Buy
44,461
+1,880
+4% +$593K 2.44% 11
2019
Q4 		$13.8M Buy
42,581
+8,262
+24% +$2.51M 1.94% 14
2019
Q3 		$10M Buy
34,319
+919
+3% +$263K 1.48% 19
2019
Q2 		$9.81M Buy
33,400
+649
+2% +$179K 1.48% 19
2019
Q1 		$8.96M Buy
+32,751
New +$8.15M 1.45% 18

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Foster Dykema Cabot & Co's TMO Position: Q3 2023 in Review

Foster Dykema Cabot & Co reduced its Thermo Fisher Scientific (TMO) stake by 0.04% in Q3 2023, selling an estimated $9.59K and leaving 42,640 shares worth $21.6M. The position accounts for 2.61% of the portfolio, ranked #10.

Foster Dykema Cabot & Co first reported a position in TMO in Q1 2019 and has held it in 19 quarters since. The position peaked at $28.2M in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Foster Dykema Cabot & Co held 42,640 shares of Thermo Fisher Scientific worth $21.6M as of Q3 2023.
  • Foster Dykema Cabot & Co sold 18 Thermo Fisher Scientific shares in Q3 2023, an estimated $9.59K.
  • Thermo Fisher Scientific made up 2.61% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #10 holding.
  • Foster Dykema Cabot & Co first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 19 quarters since.
  • Foster Dykema Cabot & Co's Thermo Fisher Scientific position peaked at $28.2M in Q4 2021.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.